HemoCue

Next week, our partners in the Pacific, Radiometer, will be exhibiting at the Australian College of Mental Health Nurses (ACMHN) Conference in Brisbane. Clozapine is an effective treatment for schizophrenia, yet its underuse is often contributed to the need for frequent blood monitoring. The HemoCue point-of-care device offers a convenient solution—enabling on-the-spot testing, with the option of a simple capillary sample, bringing care directly to the patient. Clozapine monitoring made easy — anytime, anywhere. Visit us at booth 19 to learn more about blood monitoring for compliant clozapine treatment, or visit our site here: https://lnkd.in/dzESznnh #ACMHN2025 #AdvancingCare

Follow our President, Kasper Oktavio Schweitz, on his recent Gemba trip to India! It’s great to see how these meetings and joint efforts, with partners and colleagues, can drive meaningful change. #AdvancingCare

That's a wrap on SANBTC 2025! We’re closing up the exhibition at the South African National Blood Transfusion Congress 2025 and what a fantastic two days it has been! The energy on the exhibition floor has been incredible and it's been a pleasure for our colleagues Hannah Nauhaus, Mohau Thamae and Nat Khunou to connect with so many passionate professionals in the blood services space! We’ve loved seeing the buzz around the Hb 801 system for donor screening, and attendees have been curious, engaged, and full of great questions. We’re proud to be part of the Danaher Corporation family, and it’s been a pleasure sharing a stand with Beckman Coulter Diagnostics throughout the congress. Thank you to everyone who stopped by our stand - whether it was to chat with the team, catch a live demo of the Hb 801, grab a slushy, or learn more about how we’re making diagnostics more accessible and advancing care in blood transfusion.   #AdvancingCare

As #HemoCue and other global leaders prepare for the upcoming high-level meeting on NCDs, HemoCue’s Director Alliance Development Lena Wahlhed, highlights how point-of-care screening can help break the intergenerational cycle of anemia and support a more equitable future for women and children in this article from Devex. 👉 Read the full publication on Devex here: https://lnkd.in/dic46B7R #AdvancingCare

This week, HemoCue’s President Kasper Oktavio Schweitz and Thomas Laursen, Senior Director R&D, are in India for a Gemba visit, participating in valuable Visual and Daily Management sessions focused on future innovative projects.   The sessions provided a clear view of progress, challenges, and priorities, while also highlighting the team’s strong commitment to continuous improvement and collaboration.   This visit reinforces our commitment to "Go to Gemba" — gaining insights and supporting the teams driving meaningful change. Gemba is central to Danaher’s philosophy and plays a vital role in achieving operational excellence and better serving our customers.   A big thank you to the IDC team in India and Shanti PI for the warm welcome and for sharing such valuable perspectives during the visit. We look forward to more exciting meetings in the coming days! #AdvancingCare #GembaVisit

Uncovering the hidden link: menorrhagia, iron deficiency and anemia in active women 🩸 Exercising women of reproductive age are a major at-risk population for iron deficiency (ID) and anemia due to iron loss from both exercise related processes and menstrual bleeding.   A recent population-based screening study examined the relationship between heavy menstrual bleeding (HMB), ID and anemia in recreationally active women aged 18 to 65. This study underscores the importance of proactive screening for ID and anemia for patients with HMB —conditions that remain underdiagnosed despite their prevalence and health implications. Read more about this topic and how HemoCue’s hematology solutions come into play here: https://lnkd.in/dFqCYWSK

One week to go! We’re getting ready for SANBTC 2025! HemoCue South Africa is proud to be part of the 37th South African National Blood Transfusion Congress, taking place from 25–28 August at the Birchwood Hotel in Johannesburg. You’ll find us at Stand 17, where we’ll be showcasing how our point-of-care hemoglobin solutions are supporting blood services across the country. Whether you're attending to learn, connect, or collaborate, we’d love to meet you and share how we’re helping make diagnostics more accessible. Advancing care, test by test, everywhere. 📍 Birchwood Hotel, Johannesburg 📅 25–28 August 🔎 Stand 17 – Come say hello!

Depression is a common mental illness worldwide, affecting an estimated 3.8% of the global population, with a prevalence of approximately 5.7% among adults aged 60 years and older, according to the WHO. Below you can find an interesting study aimed to explore the connection between anemia and depression in older adults, and whether treating anemia influences this relationship. The findings emphasize the importance of identifying and treating anemia in older adults—not just for physical health, but also for mental well-being. Access a link to the full study in the article below!

HemoCue AB is proud to be part of Danaher Corporation. As part of Danaher, we accelerate the power of science and technology to improve human health and deliver innovation at the #speedoflife. Learn more: https://lnkd.in/d9kShcD9

What a way to wrap up an inspiring week at ADLM in Chicago. From live demos to thought leadership sessions, our team brought the full power of Danaher Diagnostics to life. The energy at our booth was unmatched! This year marked a milestone for us. HemoCue and Danaher’s diagnostics companies came together under one roof to deliver a unified story of collaboration and advancing care. Together, we’re accelerating the real-life impact of precision diagnostics for patients around the world. One of the most exciting parts of representing at ADLM? 🗣️ “Being part of the Danaher booth and collaborating with our colleagues from other OpCos. Understanding how we can work together to meet customer needs.” A standout moment was when a customer approached us and said: 💬 “We use HemoCue! I didn’t know you were part of Danaher! We love your products – they’re workhorses.” And when our team was asked to describe the show in one word? ☝ “Synergies. Teamwork. Excitement. All because we’re part of the Danaher Diagnostics platform.” Thank you to everyone who visited us, shared your stories, and helped make this event a success. Collaboration fuels innovation and we’re excited for what’s ahead. #ADLM2025 #AdvancingCare